Sulfatase activity in normal and neoplastic endometrium

Gynecologic and Obstetric Investigation

Volumn 67, Issue 1, 2009, Pages 57-60

  Abulafia, Ovadia ^a,b   Lee, Yi Chun ^a   Wagreich, Alison ^a   Economos, Kathy ^a   Serur, Eli ^a   Nacharaju, Vijaya L ^a  

^a SUNY Downstate Medical Center   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Dehydroepiandrosterone sulfate; Endometrial carcinoma; Endometrium; Sulfatase

Indexed keywords

ANDROGEN; ESTROGEN; PRASTERONE; PRASTERONE SULFATE; STERYL SULFATASE;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; FEMALE; HORMONAL CARCINOGENESIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE HOMOGENATE;

CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, PAPILLARY; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; ENDOMETRIAL NEOPLASMS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MIXED TUMOR, MULLERIAN; STERYL-SULFATASE;

EID: 53249092472     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000161571     Document Type: Article

References (22)

1. Reed M, Purohit A: Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 1997;18:701-715.
2. Lippman ME, Swain SA: Endocrine-responsive cancers of humans; in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology. Philadelphia, Sanders, 1992, pp 1577-1597.
3. Cole MP, Jones CT, Todd ID: A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer 1971;25:270-275.
4. Smith IE, Dowsett M: Aromatase inhibitors in breast cancer. N Engl J Med 2003;348:2431-2442.
5. Milewich L, Porter JC: In situ steroid sulfatase activity in human epithelial carcinoma cells of vaginal, ovarian, and endometrial origin. J Clin Endocrinol Metab 1987;65:164-169.
6. Utsunomiya H, Ito K, Suzuki T, Kitamura T, Kaneko C, Nakata T, Niikura H, Okamura K, Yaegashi N, Sasano H: Steroid sulfatase and estrone sulfotransferase in human endometrial carcinoma. Clin Cancer Res 2004;10:5850-5856.
7. Urabe M, Yammamoto T, Naitoh K, Honjo H, Okada H: Estrone sulfatase activity in normal and neoplastic endometrial tissues of human uterus. Asia Oceania J Obstet Gynaecol 1989;15:101-106.
8. Naitoh K, Honjo H, Yamamoto T, Urabe M, O Gino Y, Yasumura T, Nambara T: Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. J Steroid Biochem 1989;6:1049-1054.
9. Zemaitis MA, Kroboth PD: Simplified procedure for measurement of serum dehydroepiandrosterone and its sulphate with gas chromatography-ion trap mass spectrometry and selected reaction monitoring. J Chromatogr B Biomed Sci Appl 1998;716:19-26.
10. Silverberg SG, Mullen D, Faraci JA, Makowski EL, Miller A, Finch JL, Sutherland JV: Endometrial carcinoma: clinical-pathogenic comparison of cases in postmenopausal women receiving and not receiving exogenous estrogens. Cancer 1980;45:3018-3026.
11. Thomas DB: Do hormones cause cancer? Cancer 1984;53:595-604.
12. Miller WR, Hawkins RA, Forrest AM: Significance of aromatase activity in human breast cancer. Cancer Res 1982;42:3365s-3368s.
13. Miller WR, Forrest AP: Oestradiol synthesis by a human breast carcinoma. Lancet 1974;2:866-868.
14. Dao TL, Hayes C, Libby PR: Steroid sulfatase activities in human breast tumors. Proc Soc Exp Biol Med 1974;146:381-384.
15. Pasqualini JR, Gelly C, Lecerf F: Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1986;8:233-240.
16. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C: Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 1996;81:1460-1464.
17. Santner SJ, Feil PD, Santen RJ: In situ estrogen production via the estrone sulfatase in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 1984;59:29-33.
18. Utsunomiya H, Suzuki T, Kaneko C, Takeyama J, Nakamura J, Kimura K, Yoshihama M, Harada N, Ito K, Konno R, Sato S, Okamura K, Sasano H: The analyses of 17β-hydroxysteroid dehydrogenase isoenzymes in human endometrial hyperplasia and carcinoma. J Clin Endocrinol Metab 2001;86:3436-3443.
19. Kazmierczak W, Skalba P, Dabkowska-Huc A, Samojedny A: Expression of aromatase and 5α-reductase genes in endometrial adenocarcinoma. Pathol Res Pract 2006;11:789-791.
20. Bulun SE, Economos K, Miller D, Simpson ER: CYP19 (aromatase cytocrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab 1994;60:1831-1834.
21. Jonegen VH, Thijssen JH, Hollema H, Donker GH, Santema JG, Van der Zee AG, Heineman MJ: Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer? Int J Gynecol Cancer 2005;15:529-536.
22. Schwartz SM, Weiss NS, Daling JR, Gammon MD, Liff JM, Watt JM, Lynch CE, Newcomb PA, Armstrong BK, Thompson WD: Exogenous sex hormones use, correlates of endogenous hormone levels, and the incidence of histological types of sarcoma of the uterus. Cancer 1996;77:717-724.